Cell Culture Monitoring Biosensor Market Growth by 2028: Growth

Cell Culture Monitoring Biosensor

Increasing application of cell culture in product research and development to augment cell culture monitoring biosensor market growth

The global cell culture monitoring biosensor market is estimated at US$332.0 million in 2020 and is expected to grow at a CAGR of 9.6% during the forecast period (2020-2027), as highlighted by a new report released by Coherent Market Insights.

Market Overview:

Cell culture is one of the primary tools used in cellular and molecular biology, providing excellent model systems for studying normal cell physiology and biochemistry, the effects of drugs and toxic compounds on cells, and mutagenesis. and carcinogenesis. The cell culture technique is often used to manufacture vaccines and biotechnology products. It is also used to develop targeted drug therapy and identify potential biomarkers. While biosensors are used to monitor several parameters (such as cell density, cell growth, contamination) and cell behavior of cell culture. The application of cell culture is quite large and evident in every product research and development in food, medicine, biotechnology and other fields.

Acquire Sample Report + All Related Charts & Graphs Study Now @ https://www.coherentmarketinsights.com/insight/request-sample/219

Competitive Landscape:

Key players operating in the global cell culture monitoring biosensor market include Lifeonics Ltd., Bruker Corporation, Cardea, Nova Biomedical, Lonza, Sarissa Biomedical Ltd., C-CIT Sensors AG, and Conductive Technologies Inc., among others.

Key Market Drivers:

High prevalence of chronic diseases, such as cancer, and growing demand for monoclonal antibodies (mAb) are expected to augment the cell culture monitoring biosensor market growth over the forecast period. For example, according to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and prostate cancer.

Additionally, the growing demand for 3D cell culture and increase in funding or investment for cell research is expected to drive the growth of the cell culture monitoring biosensor market. For example, in May 2019, TreeFrog Therapeutics raised approximately US$8.6 million in a Series A funding round for C-Stem, a 3D cell culture system used to mass-produce stem cells. with short delays while preserving genomic integrity.

COVID-19 impact analysis:

Governments around the world have implemented nationwide containment measures to curb the spread of the virus (COVID-19). The pandemic has also had a negative impact on the medical device industry in terms of supply and demand for medical devices. As a result, the growth of the global cell culture monitoring biosensor market is also expected to witness a slowdown.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/219

Key points to remember:

• The cell culture monitoring biosensor market is expected to grow at a CAGR of 9.6% during the forecast period owing to the growing focus on the development of new drugs and therapeutics and the growing focus on personalized medicine. For example, in January 2022, TTP Plc. and CellFiber announced a new strategic partnership to revolutionize cell manufacturing and deliver much-needed therapies to millions of people around the world. Stem cell therapy has been shown to have a transformative impact in treating some of the most devastating diseases, such as heart disease, diabetes, cancer and Parkinson’s disease.

• Among regions, North America, Europe and Asia-Pacific are expected to witness robust growth in the cell culture monitoring biosensors market owing to the increased awareness of cell culture monitoring biosensors, from increased funding/investments for cellular research, increased production of biopharmaceuticals, increased demand for targeted therapies and increased incidence of chronic diseases in these regions.

• For example, in March 2019, Lonza launched CellBio Services, a comprehensive portfolio of solutions designed to meet the specific and individual needs of research applications. Researchers in pharmaceutical and contract manufacturing organizations can now choose from a wide range of services, including cell line expansion and banking, media production, cell isolation, cell characterization, transfection and 3D cell culture services.

Buy this full activity report @ https://www.coherentmarketinsights.com/insight/buy-now/219

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insight in various post-COVID-19 industries and to continuing to deliver measurable and sustainable results to our clients.

Contact us:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This press release was published on openPR.

Comments are closed.